| NCT ID | NCT06032975 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Naples |
| Condition | Ovarian Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2023-10-30 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2023-10-30 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for OC patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
Eligibility Criteria
Inclusion Criteria: * Written informed consent provided; * Women ≥18 years; * Histologically or citologically confirmed diagnosis of epithelial ovarian, fallopian tube or peritoneal cancer stage IC-IV according to FIGO staging system; * Patients who are close to begin any type of medical treatment against ovarian cancer. Exclusion Criteria: * Major cognitive dysfunction or psychiatric disorders; * Patients with epithelial ovarian, fallopian tube or peritoneal cancer candidate exclusively to follow-up; * Patients who have received more than 4 previous lines of medical treatment (maintenance treatments do not represent a line).
Contact & Investigator
Sandro Pignata, MD, PhD
PRINCIPAL INVESTIGATOR
National Cancer Institute, Naples
Frequently Asked Questions
Who can join the NCT06032975 clinical trial?
This trial is open to female participants only, studying Ovarian Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06032975 currently recruiting?
Yes, NCT06032975 is actively recruiting participants. Contact the research team at c.schettino@istitutotumori.na.it for enrollment information.
Where is the NCT06032975 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT06032975 clinical trial?
NCT06032975 is sponsored by National Cancer Institute, Naples. The principal investigator is Sandro Pignata, MD, PhD at National Cancer Institute, Naples. The trial plans to enroll 240 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.